Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at JMP Securities
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.91 -0.69%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
JMP Securities analyst Jason Butler lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $35.00 (from $42.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- LEG Immobilien AG (LEG:GR) (LEGIF) PT Lowered to EUR60 at Morgan Stanley
- Citi Downgrades LexinFintech Holdings (ADR) (LX) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
